Amgen Files 8-K on Financials and Exhibits
Ticker: AMGN · Form: 8-K · Filed: Aug 5, 2025 · CIK: 318154
| Field | Detail |
|---|---|
| Company | Amgen INC (AMGN) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, debt
Related Tickers: AMGN
TL;DR
Amgen dropped an 8-K on Aug 5th covering financials and exhibits - check it out.
AI Summary
Amgen Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details information related to its common stock and senior notes due in 2026.
Why It Matters
This filing provides investors with updated financial information and disclosures, which are crucial for assessing the company's performance and investment potential.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant risks.
Key Players & Entities
- Amgen Inc. (company) — Registrant
- August 5, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-37702 (commission_file_number) — SEC File Number
- 95-3540776 (ein) — IRS Employer Identification No.
- One Amgen Center Drive, Thousand Oaks, California 91320-1799 (address) — Principal Executive Offices
- (805) 447-1000 (phone_number) — Registrant's telephone number
- A2.00 Senior Notes Due 2026 (financial_instrument) — Debt Instrument Mentioned
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Amgen Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on August 5, 2025.
In which U.S. state is Amgen Inc. incorporated?
Amgen Inc. is incorporated in Delaware.
What is the SEC file number for Amgen Inc.?
The SEC file number for Amgen Inc. is 001-37702.
What specific financial instruments are mentioned in the filing details?
The filing details mention Amgen's common stock and its A2.00 Senior Notes Due 2026.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding AMGEN INC (AMGN).